Hypophosphatemic Rickets clinical trials at UCSF

1 in progress, 0 open to eligible people

Showing trials for

  • X-linked Hypophosphatemia Disease Monitoring Program

    Sorry, in progress, not accepting new patients

    The objectives of this observational study are to characterize XLH disease presentation and progression and to assess long-term effectiveness and safety of burosumab.

    San Francisco, California and other locations

Our lead scientists for Hypophosphatemic Rickets research studies include .

Last updated: